China Health Group Limited (“China Health”) announced that every item on the agenda of its Annual General Meeting (AGM) held on 22 September 2026 was approved by poll with 100.00% of votes cast in favour.

Turnout and Voting Details • Shareholders representing 608.17 million shares—equivalent to 43.83% of the total 1.39 billion shares outstanding—voted at the meeting. • All eight ordinary resolutions secured unanimous backing, with zero votes against.

Key Approvals 1. FY26 Financials: Audited consolidated financial statements for the fiscal year ended 31 March 2026, together with directors’ and auditors’ reports, were adopted. 2. Board Composition: Seven directors—Mr. Cao Xu, Ms. Ying Rensi, Mr. Ying Wei, Mr. Huang Lianhai, Mr. Wu Hui, Mr. Li Hongyi—were re-elected. Authority was also granted for the Board to appoint additional directors and set directors’ remuneration. 3. Auditor: Beijing Xinghua Caplegend CPA Limited was re-appointed, with the Board authorised to determine its remuneration. 4. Capital Mandates: • General mandate to issue new shares up to 20% of issued share capital. • Share repurchase mandate up to 10% of issued share capital. • Extension mandate allowing the issue mandate to be increased by the number of shares repurchased. 5. Equity Incentive Limits: The Scheme Mandate Limit and the Service Provider Sublimit under the share option scheme were refreshed.

Administrative Notes • No shareholders abstained or voted against any resolution, and no counter-proposals were recorded. • Tricor Investor Services Limited acted as scrutineer for the poll. • All directors except Mr. Huang Lianhai attended the AGM in person or electronically.

The full endorsement of all resolutions provides China Health with renewed flexibility for capital management and board composition as it executes its strategic plans for the coming fiscal year.